|
|
Article: Group Studies Estrogen Receptors And Cancer Prevention In Chronic Hepatitis C.
- Article from:
- Women's Health Weekly
- Article date:
- November 8, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 NOV 8 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Estrogen, a hormone rarely mentioned without inciting controversy, may prevent liver cancer in patients chronically infected with hepatitis C virus (HCV).
Medical researchers in Japan have confirmed that estrogen receptors (ERs) on the liver, which modulate estrogen activity, could be the link to cancer prevention, based on a study of over 1100 individuals with chronic hepatitis C-related liver cirrhosis. Cirrhosis is a risk factor for a form of primary liver cancer known as hepatocellular carcinoma (HCC).
"This study was performed to assess possible implications of ...